ICH M13 Guidance and Health Canada [Regulatives / Guidelines]

posted by AB661 – India, 2024-10-01 07:09 (33 d 17:43 ago) – Posting: # 24207
Views: 588

Dear All,

Query is with reference to BE study Submission to Health Canada.
As per current health Canada BE guidance, only T/R ratio requires for Cmax not 90 % CI criteria. After implementation of ICH M13 (A, B, C) Guidance, whether Health Canada will revise acceptance criteria for Cmax?


With regards
AB661

Complete thread:

UA Flag
Activity
 Admin contact
23,280 posts in 4,889 threads, 1,655 registered users;
85 visitors (0 registered, 85 guests [including 14 identified bots]).
Forum time: 23:53 CET (Europe/Vienna)

Freedom is always and exclusively
freedom for the one
who thinks differently.    Rosa Luxemburg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5